Trendlines Enters into MOU with Singapore’s National Healthcare Group

Editor’s note: News of the MOU appeared in BT Invest, The Business Times, and The Straits Times. 

NHG Trendlines MOU signing ceremony

Financial PR’s Reyna Mei open the signing ceremony between Singapore’s National Healthcare Group and Trendlines Medical Singapore.

The purpose of the MOU is to establish a partnership and co-develop innovative healthcare solutions.

Trendlines Medical Singapore and the National Healthcare Group (NHG), a company that is part of Singapore’s Ministry of Health,  jointly announced that Trendlines Singapore and NHG have entered into a Memorandum of Understanding (MOU) to establish a partnership between NHG and Trendlines Singapore focused on collaborating  in identifying clinical unmet needs and developing innovative technological solutions to address these needs for local and global clinical demands. Read the full announcement.

The MOU will leverage the clinical expertise of NHG clinicians and healthcare professionals, as well as the innovation and technological expertise of Trendlines and its affiliated companies. Under the MOU, NHG will identify key problem statements and unmet clinical needs, while Trendlines Medical Singapore and its affiliated companies will develop innovative solutions to address these needs. NHG and Trendlines will collaborate closely and jointly refine the development through clinical validation of solutions within the clinical infrastructure of NHG.

Signing ceremony between the NHG and Trendlines (l to r): Associate Professor and Chairman Medical Board at Tan Tock Seng Hospital and Director, Centre for Medical Technologies and Innovations, NHG Thomas Lew;  Adjunct Professor and Deputy Group CEO (Education & Research), NHG Lim Tock Han; Chairman and CEO The Trendlines Group and Chairman Trendlines Medical Singapore Todd Dollinger, CEO Trendlines Medical Singapore Eric Loh. 

NHG and Trendlines Singapore have already identified three potential areas of collaboration:

  1. Developing innovations to improve the condition of inpatients with fragile skin
  2. Developing more efficient ways to monitor vital signs
  3. Finding more effective solutions to ensure the safe delivery of nutrition to patients

Eric Loh, CEO of Trendlines Singapore, commented, “We provide business and technology incubation to our portfolio companies in order for them to develop excellent medical products that address unmet clinical needs. … This collaboration with NHG will enable us to expand our scope of technology development, and it gives our companies the opportunity to receive good clinical validation and potential product adoption. We are confident that this first collaboration with healthcare institutions here will add value to the healthcare ecosystem and create accretive success to the medical technology start-up environment in Singapore.”

Associate Professor Thomas Lew, Chairman Medical Board at Tan Tock Seng Hospital and Director, Centre for Medical Technologies and Innovations, NHG: “The Centre for Medical Technologies and Innovation (CMTi) was established to … translate innovative ideas into practical working solutions and products. Through CMTi, NHG is privileged to partner with Trendlines Singapore through our MOU to foster closer collaboration in co-developing clinical, needs-driven healthcare-related technological solutions. …”

Adjunct Professor Lim Tock Han, Deputy Group CEO (Education & Research) of NHG: “Good population health – comprising physical, social and mental well-being – is a shared responsibility that must be owned by all sectors, not just public healthcare. NHG believes in forging collaborations with partners such as Trendlines to develop innovative solutions to deliver better care for our population, to empower people to better manage their health and to encourage them to adopt healthier lifestyles.”

Todd Dollinger, Chairman of Trendlines Singapore and CEO and Chairman of The Trendlines Group: “… We are confident that combining our expertise with the strong clinical standing of the hospitals and physicians of NHG, we will see successful companies and medical solutions developed, not just to address the local market, but also the global landscape facing similar medical concerns.”

Leave a Reply

  • Welcome to Trendlines

    We invest in, incubate, and support early-stage, high-promise medical and agricultural technology companies in Israel, a global leader in start-up ingenuity. Read More >

  • Categories

  • Subscribe to Our Newsletter

  • Stay in Touch

    icon-facebook Like us on Facebook

    icon-Twitter Follow us on Twitter

    icon-Linkedin Connect with us on Linkedin

    YouTube-color See us on YouTube

    flipboard  Read us on Flipboard

    google+_icon Join us on Google+

Font Resize